Paraoxonase polymorphism MET-LEU 54 is associated with fatal myocardial infarction in type 2 diabetic patients

Registros relacionados

• Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
  por: Stevens, R, et al.
  Publicado em: (2004)
• Silent myocardial infarction is an independent risk factor for fatal myocardial infarction in patients with Type 2 diabetes
  por: Cull, C, et al.
  Publicado em: (2007)
• Serum myeloperoxidase, paraoxonase, and plasma asprosin concentrations in patients with acute myocardial infarction
  por: Handan Ciftci, et al.
  Publicado em: (2024-04-01)
• UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.
  por: Keavney, B, et al.
  Publicado em: (1995)
• Ethnicity and cardiovascular disease. The incidence of myocardial infarction in white, South Asian, and Afro-Caribbean patients with type 2 diabetes (U.K. Prospective Diabetes Study 32).
  por: Adler, A, et al.
  Publicado em: (1998)